Lens epithelium-derived growth factor p75 splice variant (LEDGF) is a chromatin-binding protein known for its antiapoptotic activity and ability to direct human immunodeficiency virus into active transcription units. Here we show that LEDGF promotes the repair of DNA double-strand breaks (DSBs) by the homologous recombination repair pathway. Depletion of LEDGF impairs the recruitment of C-terminal binding protein interacting protein (CtIP) to DNA DSBs and the subsequent CtIP-dependent DNA-end resection. LEDGF is constitutively associated with chromatin through its Pro-Trp-Trp-Pro (PWWP) domain that binds preferentially to epigenetic methyl-lysine histone markers characteristic of active transcription units. LEDGF binds CtIP in a DNA damage-dependent manner, thereby enhancing its tethering to the active chromatin and facilitating its access to DNA DSBs. These data highlight the role of PWWP-domain proteins in DNA repair and provide a molecular explanation for the antiapoptotic and cancer cell survival-activities of LEDGF.
- MeSH
- Adaptor Proteins, Signal Transducing * antagonists & inhibitors genetics metabolism MeSH
- Apoptosis MeSH
- Chromatin metabolism MeSH
- DNA Breaks, Double-Stranded MeSH
- HeLa Cells MeSH
- HIV genetics MeSH
- Nuclear Proteins metabolism MeSH
- Humans MeSH
- RNA, Small Interfering genetics MeSH
- Cell Line, Tumor MeSH
- Recombinational DNA Repair * physiology MeSH
- RNA Interference MeSH
- Transcription Factors * antagonists & inhibitors genetics metabolism MeSH
- Carrier Proteins metabolism MeSH
- Cell Survival MeSH
- Check Tag
- Humans MeSH
The replication protein A (RPA) is involved in most, if not all, nuclear metabolism involving single-stranded DNA. Here, we show that RPA is involved in genome maintenance at stalled replication forks by the homologous recombination repair system in humans. Depletion of the RPA protein inhibited the formation of RAD51 nuclear foci after hydroxyurea-induced replication stalling leading to persistent unrepaired DNA double-strand breaks (DSBs). We demonstrate a direct role of RPA in homology directed recombination repair. We find that RPA is dispensable for checkpoint kinase 1 (Chk1) activation and that RPA directly binds RAD52 upon replication stress, suggesting a direct role in recombination repair. In addition we show that inhibition of Chk1 with UCN-01 decreases dissociation of RPA from the chromatin and inhibits association of RAD51 and RAD52 with DNA. Altogether, our data suggest a direct role of RPA in homologous recombination in assembly of the RAD51 and RAD52 proteins. Furthermore, our data suggest that replacement of RPA with the RAD51 and RAD52 proteins is affected by checkpoint signalling.
- MeSH
- Enzyme Activation MeSH
- Genes, cdc MeSH
- Rad52 DNA Repair and Recombination Protein genetics metabolism MeSH
- Hydroxyurea metabolism MeSH
- Nucleic Acid Synthesis Inhibitors metabolism MeSH
- Humans MeSH
- Cell Line, Tumor MeSH
- DNA Repair * MeSH
- DNA Damage MeSH
- Protein Kinases genetics metabolism MeSH
- Rad51 Recombinase metabolism MeSH
- DNA Replication * MeSH
- Replication Protein A genetics metabolism MeSH
- Signal Transduction * physiology MeSH
- Check Tag
- Humans MeSH
Human checkpoint kinase 1 (Chk1) is an essential kinase required to preserve genome stability. Here, we show that Chk1 inhibition by two distinct drugs, UCN-01 and CEP-3891, or by Chk1 small interfering RNA (siRNA) leads to phosphorylation of ATR targets. Chk1-inhibition triggered rapid, pan-nuclear phosphorylation of histone H2AX, p53, Smc1, replication protein A, and Chk1 itself in human S-phase cells. These phosphorylations were inhibited by ATR siRNA and caffeine, but they occurred independently of ATM. Chk1 inhibition also caused an increased initiation of DNA replication, which was accompanied by increased amounts of nonextractable RPA protein, formation of single-stranded DNA, and induction of DNA strand breaks. Moreover, these responses were prevented by siRNA-mediated downregulation of Cdk2 or the replication initiation protein Cdc45, or by addition of the CDK inhibitor roscovitine. We propose that Chk1 is required during normal S phase to avoid aberrantly increased initiation of DNA replication, thereby protecting against DNA breakage. These results may help explain why Chk1 is an essential kinase and should be taken into account when drugs to inhibit this kinase are considered for use in cancer treatment.
- MeSH
- Ataxia Telangiectasia Mutated Proteins MeSH
- Checkpoint Kinase 2 MeSH
- Chromosomal Proteins, Non-Histone metabolism MeSH
- DNA-Binding Proteins metabolism MeSH
- Phosphorylation MeSH
- Histones metabolism MeSH
- Protein Kinase Inhibitors pharmacology MeSH
- DNA, Single-Stranded metabolism MeSH
- Caffeine pharmacology MeSH
- Humans MeSH
- RNA, Small Interfering pharmacology genetics MeSH
- Tumor Suppressor Protein p53 metabolism MeSH
- DNA Damage * physiology MeSH
- Protein Serine-Threonine Kinases physiology drug effects MeSH
- Protein Kinases pharmacology physiology genetics MeSH
- Cell Cycle Proteins physiology genetics metabolism MeSH
- Purines pharmacology MeSH
- DNA Replication physiology drug effects MeSH
- Replication Protein A MeSH
- Staurosporine * analogs & derivatives pharmacology MeSH
- Check Tag
- Humans MeSH
The essential checkpoint kinase Chk1 is required for cell-cycle delays after DNA damage or blocked DNA replication. However, it is unclear whether Chk1 is involved in the repair of damaged DNA. Here we establish that Chk1 is a key regulator of genome maintenance by the homologous recombination repair (HRR) system. Abrogation of Chk1 function with small interfering RNA or chemical antagonists inhibits HRR, leading to persistent unrepaired DNA double-strand breaks (DSBs) and cell death after replication inhibition with hydroxyurea or DNA-damage caused by camptothecin. After hydroxyurea treatment, the essential recombination repair protein RAD51 is recruited to DNA repair foci performing a vital role in correct HRR. We demonstrate that Chk1 interacts with RAD51, and that RAD51 is phosphorylated on Thr 309 in a Chk1-dependent manner. Consistent with a functional interplay between Chk1 and RAD51, Chk1-depleted cells failed to form RAD51 nuclear foci after exposure to hydroxyurea, and cells expressing a phosphorylation-deficient mutant RAD51(T309A) were hypersensitive to hydroxyurea. These results highlight a crucial role for the Chk1 signalling pathway in protecting cells against lethal DNA lesions through regulation of HRR.
- MeSH
- DNA-Binding Proteins metabolism MeSH
- DNA MeSH
- Hydroxyurea pharmacology MeSH
- Camptothecin pharmacology MeSH
- Cricetinae MeSH
- Humans MeSH
- DNA Repair * MeSH
- DNA Damage MeSH
- Protein Kinases * physiology MeSH
- Recombination, Genetic * MeSH
- Rad51 Recombinase MeSH
- Signal Transduction MeSH
- Animals MeSH
- Check Tag
- Cricetinae MeSH
- Humans MeSH
- Animals MeSH
The human checkpoint kinase Chk1 has been suggested as a target for cancer treatment. Here, we show that a new inhibitor of Chk1 kinase, CEP-3891, efficiently abrogates both the ionizing radiation (IR)-induced S and G(2) checkpoints. When the checkpoints were abrogated by CEP-3891, the majority (64%) of cells showed fragmented nuclei at 24 hours after IR (6 Gy). The formation of nuclear fragmentation in IR-treated human cancer cells was directly visualized by time-lapse video microscopy of U2-OS cells expressing a green fluorescent protein-tagged histone H2B protein. Nuclear fragmentation occurred as a result of defective chromosome segregation when irradiated cells entered their first mitosis, either prematurely without S and G(2) checkpoint arrest in the presence of CEP-3891 or after a prolonged S and G(2) checkpoint arrest in the absence of CEP-3891. The nuclear fragmentation was clearly distinguishable from apoptosis because caspase activity and nuclear condensation were not induced. Finally, CEP-3891 not only accelerated IR-induced nuclear fragmentation, it also increased the overall cell killing after IR as measured in clonogenic survival assays. These results demonstrate that transient Chk1 inhibition by CEP-3891 allows premature mitotic entry of irradiated cells, thereby leading to accelerated onset of mitotic nuclear fragmentation and increased cell death.
- MeSH
- Apoptosis drug effects physiology radiation effects MeSH
- Cell Nucleus * drug effects radiation effects MeSH
- G2 Phase * drug effects radiation effects MeSH
- Protein Kinase Inhibitors * pharmacology MeSH
- Humans MeSH
- Mitosis physiology drug effects radiation effects MeSH
- Cell Line, Tumor MeSH
- Bone Neoplasms enzymology drug therapy pathology radiotherapy MeSH
- Osteosarcoma enzymology drug therapy pathology radiotherapy MeSH
- Protein Kinases * metabolism MeSH
- Radiation-Sensitizing Agents pharmacology MeSH
- S Phase * drug effects radiation effects MeSH
- Cell Survival radiation effects MeSH
- Check Tag
- Humans MeSH
The ATR and Chk1 kinases are essential to maintain genomic integrity. ATR, with Claspin and the Rad9-Rad1-Hus1 complex, activates Chk1 after DNA damage. Chk1-mediated phosphorylation of the Cdc25A phosphatase is required for the mammalian S-phase checkpoint. Here, we show that during physiological S phase the regulation of the Chk1-Cdc25A pathway depends on ATR, Claspin, Rad9, and Hus1. Human cells with chemically or genetically ablated ATR showed inhibition of Chk1-dependent phosphorylation of Cdc25A, and they accumulated Cdc25A without external DNA damage. Furthermore, siRNA-mediated depletion of Claspin, Rad9 and Hus1 also stabilized Cdc25A. ATR ablation also inhibited the activatory phosphorylation of Chk1 on serine 345. Thus, the ATR-Chk1-Cdc25A pathway represents an integral part of physiological S-phase progression, and interference with this mechanism undermines viability of somatic mammalian cells. DNA damage further activates and switches this pathway from its constitutively operating "surveillance mode" compatible with DNA replication into an "emergency" checkpoint response.
- MeSH
- Adaptor Proteins, Signal Transducing genetics metabolism MeSH
- Ataxia Telangiectasia Mutated Proteins MeSH
- Down-Regulation physiology MeSH
- Exonucleases genetics metabolism MeSH
- cdc25 Phosphatases genetics metabolism MeSH
- Phosphorylation MeSH
- Humans MeSH
- RNA, Small Interfering genetics metabolism MeSH
- Tumor Cells, Cultured MeSH
- Genomic Instability physiology MeSH
- DNA Damage genetics MeSH
- Protein Serine-Threonine Kinases genetics metabolism MeSH
- Protein Kinases genetics metabolism MeSH
- Cell Cycle Proteins genetics metabolism MeSH
- DNA Replication physiology MeSH
- S Phase physiology MeSH
- Schizosaccharomyces pombe Proteins genetics metabolism MeSH
- Signal Transduction physiology MeSH
- Check Tag
- Humans MeSH
Deregulation of the RB pathway is shared by most human malignancies. Components upstream of the retinoblastoma tumour suppressor (pRB), namely the INK4 family of cyclin-dependent kinase (CDK) inhibitors, the D-type cyclins, their partner kinases CDK4/CDK6, and pRB as their critical substrate, are differentially targeted in diverse types of cancer. An 'unorthodox' spectrum of defects within this cascade occurs in testicular germ cell tumours (TGCTs), including silencing of pRB transcription, overexpression of cyclin D2, and loss of p18INK4c. To improve understanding of the role of this pathway in spermatogenesis, and its subversion in TGCTs, we examined immunohistochemical expression patterns of CDK4, p16INK4a, p15INK4b, and pRB, and established an in situ assay for cyclin D-mediated phosphorylation of serine795, a phosphorylation event critical for neutralization of pRB's growth-restraining ability. pRB was expressed throughout adult spermatogenesis and was detectable in teratomas, but was absent or grossly reduced in carcinoma in situ (CIS) and most seminomas and embryonal carcinomas. Unexpectedly, we also found that pRB was absent from fetal human gonocytes, the candidate target cell for all types of TGCTs. Thus, rather than a tumorigenesis-promoting loss of pRB, the lack of pRB in TGCTs likely reflects its developmental control. Widespread expression of p15INK4b, found in normal testes, was preserved in TGCTs. In contrast, p16INK4a was lost or reduced in large subsets of TGCTs. CDK4 was expressed in normal spermatogonia, CIS, and invasive TGCTs, as was serine795-phosphorylated pRB. Our data on expression of pRB support the plausible origin of TGCTs from fetal gonocytes, and the serine795 phosphorylation demonstrates that the cyclin D-dependent kinases are active, and neutralize pRB in spermatogonia and in those TGCTs that express pRB. We hope that this study will inspire further immunohistochemical applications of phosphospecific antibodies in pathology, and examination of the RB pathway defects in relation to curability of TGCTs. Copyright 2003 John Wiley & Sons, Ltd.
- MeSH
- Cell Cycle MeSH
- Adult MeSH
- Carcinoma, Embryonal metabolism MeSH
- Phosphorylation MeSH
- Germinoma * physiopathology MeSH
- Immunoenzyme Techniques MeSH
- Carcinoma in Situ metabolism MeSH
- Cells, Cultured MeSH
- Humans MeSH
- Infant, Newborn MeSH
- Retinoblastoma Protein * physiology MeSH
- Seminoma metabolism MeSH
- Teratoma metabolism MeSH
- Testicular Neoplasms * physiopathology MeSH
- Testis metabolism MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Male MeSH
- Infant, Newborn MeSH
Chk1 kinase coordinates cell cycle progression and preserves genome integrity. Here, we show that chemical or genetic ablation of human Chk1 triggered supraphysiological accumulation of the S phase-promoting Cdc25A phosphatase, prevented ionizing radiation (IR)-induced degradation of Cdc25A, and caused radioresistant DNA synthesis (RDS). The basal turnover of Cdc25A operating in unperturbed S phase required Chk1-dependent phosphorylation of serines 123, 178, 278, and 292. IR-induced acceleration of Cdc25A proteolysis correlated with increased phosphate incorporation into these residues generated by a combined action of Chk1 and Chk2 kinases. Finally, phosphorylation of Chk1 by ATM was required to fully accelerate the IR-induced degradation of Cdc25A. Our results provide evidence that the mammalian S phase checkpoint functions via amplification of physiologically operating, Chk1-dependent mechanisms.
- MeSH
- Enzyme Activation MeSH
- Ataxia Telangiectasia Mutated Proteins MeSH
- Models, Biological MeSH
- Cell Cycle * physiology radiation effects MeSH
- Checkpoint Kinase 2 MeSH
- DNA-Binding Proteins MeSH
- cdc25 Phosphatases * physiology radiation effects MeSH
- Phosphorylation MeSH
- HeLa Cells MeSH
- Radiation, Ionizing MeSH
- Kinetics MeSH
- Humans MeSH
- Tumor Cells, Cultured MeSH
- Tumor Suppressor Proteins MeSH
- Protein Serine-Threonine Kinases physiology MeSH
- Protein Kinases * metabolism MeSH
- Cell Cycle Proteins MeSH
- DNA Replication radiation effects MeSH
- S Phase radiation effects MeSH
- Serine metabolism MeSH
- Signal Transduction MeSH
- Check Tag
- Humans MeSH
Periodic activity of the anaphase-promoting complex (APC) ubiquitin ligase determines progression through multiple cell cycle transitions by targeting cell cycle regulators for destruction. At the G(1)/S transition, phosphorylation-dependent dissociation of the Cdh1-activating subunit inhibits the APC, allowing stabilization of proteins required for subsequent cell cycle progression. Cyclin-dependent kinases (CDKs) that initiate and maintain Cdh1 phosphorylation have been identified. However, the issue of which cyclin-CDK complexes are involved has been a matter of debate, and the mechanism of how cyclin-CDKs interact with APC subunits remains unresolved. Here we substantiate the evidence that mammalian cyclin A-Cdk2 prevents unscheduled APC reactivation during S phase by demonstrating its periodic interaction with Cdh1 at the level of endogenous proteins. Moreover, we identified a conserved cyclin-binding motif within the Cdh1 WD-40 domain and show that its disruption abolished the Cdh1-cyclin A-Cdk2 interaction, eliminated Cdh1-associated histone H1 kinase activity, and impaired Cdh1 phosphorylation by cyclin A-Cdk2 in vitro and in vivo. Overexpression of cyclin binding-deficient Cdh1 stabilized the APC-Cdh1 interaction and induced prolonged cell cycle arrest at the G(1)/S transition. Conversely, cyclin binding-deficient Cdh1 lost its capability to support APC-dependent proteolysis of cyclin A but not that of other APC substrates such as cyclin B and securin Pds1. Collectively, these data provide a mechanistic explanation for the mutual functional interplay between cyclin A-Cdk2 and APC-Cdh1 and the first evidence that Cdh1 may activate the APC by binding specific substrates.
- MeSH
- Anaphase MeSH
- Anaphase-Promoting Complex-Cyclosome MeSH
- Cell Cycle MeSH
- Cyclin A * metabolism MeSH
- Cyclin-Dependent Kinase 2 MeSH
- Cyclin-Dependent Kinases metabolism MeSH
- Fibroblasts cytology metabolism MeSH
- G1 Phase MeSH
- CDC2-CDC28 Kinases * MeSH
- Ubiquitin-Protein Ligase Complexes * MeSH
- Conserved Sequence * MeSH
- Rats MeSH
- Cells, Cultured MeSH
- Humans MeSH
- Ligases genetics metabolism MeSH
- Molecular Sequence Data MeSH
- Tumor Cells, Cultured MeSH
- Protein Serine-Threonine Kinases * metabolism MeSH
- S Phase MeSH
- Amino Acid Sequence MeSH
- Substrate Specificity MeSH
- Ubiquitin-Protein Ligases MeSH
- Ubiquitins metabolism MeSH
- Binding Sites MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Animals MeSH
Ubiquitin-proteasome-mediated destruction of rate-limiting proteins is required for timely progression through the main cell cycle transitions. The anaphase-promoting complex (APC), periodically activated by the Cdh1 subunit, represents one of the major cellular ubiquitin ligases which, in Saccharomyces cerevisiae and Drosophila spp., triggers exit from mitosis and during G(1) prevents unscheduled DNA replication. In this study we investigated the importance of periodic oscillation of the APC-Cdh1 activity for the cell cycle progression in human cells. We show that conditional interference with the APC-Cdh1 dissociation at the G(1)/S transition resulted in an inability to accumulate a surprisingly broad range of critical mitotic regulators including cyclin B1, cyclin A, Plk1, Pds1, mitosin (CENP-F), Aim1, and Cdc20. Unexpectedly, although constitutively assembled APC-Cdh1 also delayed G(1)/S transition and lowered the rate of DNA synthesis during S phase, some of the activities essential for DNA replication became markedly amplified, mainly due to a progressive increase of E2F-dependent cyclin E transcription and a rapid turnover of the p27(Kip1) cyclin-dependent kinase inhibitor. Consequently, failure to inactivate APC-Cdh1 beyond the G(1)/S transition not only inhibited productive cell division but also supported slow but uninterrupted DNA replication, precluding S-phase exit and causing massive overreplication of the genome. Our data suggest that timely oscillation of the APC-Cdh1 ubiquitin ligase activity represents an essential step in coordinating DNA replication with cell division and that failure of mechanisms regulating association of APC with the Cdh1 activating subunit can undermine genomic stability in mammalian cells.
- MeSH
- Anaphase-Promoting Complex-Cyclosome MeSH
- Cell Cycle * MeSH
- Cyclin E metabolism MeSH
- Cyclin-Dependent Kinase 2 MeSH
- Cyclin-Dependent Kinases metabolism MeSH
- DNA-Binding Proteins * MeSH
- Fluorescent Antibody Technique MeSH
- Interphase drug effects MeSH
- CDC2-CDC28 Kinases * MeSH
- Ubiquitin-Protein Ligase Complexes * MeSH
- Humans MeSH
- Ligases * metabolism MeSH
- Macromolecular Substances MeSH
- Mitosis * MeSH
- Tumor Cells, Cultured MeSH
- Cdc20 Proteins MeSH
- Protein Serine-Threonine Kinases metabolism MeSH
- Cell Cycle Proteins metabolism MeSH
- Drosophila Proteins * MeSH
- Antibodies pharmacology MeSH
- Flow Cytometry MeSH
- DNA Replication * MeSH
- Saccharomyces cerevisiae Proteins * MeSH
- Trans-Activators * MeSH
- Transcription Factor DP1 MeSH
- E2F Transcription Factors MeSH
- Transcription Factors metabolism MeSH
- Carrier Proteins * MeSH
- Ubiquitin-Protein Ligases MeSH
- Protein Binding MeSH
- Retinoblastoma-Binding Protein 1 MeSH
- Blotting, Western MeSH
- Check Tag
- Humans MeSH